Westlake Chemical Partners (NYSE:WLKP) Issues Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Westlake Chemical Partners (NYSE:WLKPGet Free Report) announced its earnings results on Tuesday. The basic materials company reported $0.41 earnings per share for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.01), Zacks reports. Westlake Chemical Partners had a net margin of 4.34% and a return on equity of 6.00%. The company had revenue of $323.05 million for the quarter, compared to analysts’ expectations of $313.00 million.

Here are the key takeaways from Westlake Chemical Partners’ conference call:

  • Renewal of the Ethylene Sales Agreement through 2027 under unchanged terms reinforces predictable, fee-based cash flows and shows Westlake’s continued sponsor support.
  • Full-year 2025 results were weaker as net income fell to $49 million (down $13 million) and MLP distributable cash flow declined to $53 million (down $14 million) due to the planned Petro 1 turnaround, leaving a 2025 distribution coverage ratio of 0.8x.
  • With no planned turnarounds in 2026, management expects production and sales volumes to recover, which should drive distributable cash flow and coverage back toward historical levels.
  • Liquidity and balance-sheet metrics remain solid — consolidated cash of $68 million, an operating surplus of ~ $74 million, long-term debt of $400 million, and consolidated leverage below 1x — supporting 46 consecutive quarterly distributions.
  • Management outlined growth levers (increasing OpCo ownership, acquisitions, organic expansions, or negotiating a higher fixed margin) and said any moves would be financed via drop-downs and a mix of new units and debt, which could affect leverage or unit dilution if executed.

Westlake Chemical Partners Price Performance

Shares of WLKP stock traded up $0.72 during trading hours on Wednesday, hitting $21.96. The stock had a trading volume of 10,503 shares, compared to its average volume of 51,431. The stock has a market capitalization of $773.91 million, a price-to-earnings ratio of 15.75, a PEG ratio of 2.28 and a beta of 0.59. The stock’s 50-day moving average price is $20.50 and its two-hundred day moving average price is $20.39. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.37 and a quick ratio of 2.32. Westlake Chemical Partners has a one year low of $17.75 and a one year high of $24.70.

Westlake Chemical Partners Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 23rd. Stockholders of record on Friday, February 6th were given a dividend of $0.4714 per share. The ex-dividend date was Friday, February 6th. This represents a $1.89 dividend on an annualized basis and a dividend yield of 8.6%. Westlake Chemical Partners’s dividend payout ratio (DPR) is presently 135.00%.

Key Headlines Impacting Westlake Chemical Partners

Here are the key news stories impacting Westlake Chemical Partners this week:

  • Positive Sentiment: Management said it expects a recovery in distributable cash flow in 2026 and confirmed no planned turnarounds next year — a positive for unit-level cash available for distribution and payout stability. Article Title
  • Positive Sentiment: Several outlets framed the quarter as a modest beat on earnings/profit metrics and emphasized the outlook/management commentary, which likely supported a positive market reaction. Article Title
  • Neutral Sentiment: Revenue of $323.05M topped consensus (~$313M), showing demand resilience even as profitability metrics were mixed. Article Title
  • Neutral Sentiment: Company released its formal Q4 & full-year press release detailing net income and cash-flow figures; net income was roughly flat year-over-year. Article Title
  • Negative Sentiment: EPS came in at $0.41, missing the Street by $0.01 — a small miss but a near-term headwind for sentiment. Article Title
  • Negative Sentiment: Cash flows from operating activities fell to $120.4M (down $12.1M vs. prior year), which could pressure distribution coverage until DCF recovery materializes. Article Title
  • Neutral Sentiment: Full earnings-call transcript and multiple recaps (Seeking Alpha, The Motley Fool) provide detail for investors; check the call for commentary on volumes, pricing and 2026 assumptions. Article Title

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the company. Wall Street Zen raised Westlake Chemical Partners from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 14th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Westlake Chemical Partners in a research report on Monday, December 29th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Hold”.

Check Out Our Latest Stock Report on Westlake Chemical Partners

Institutional Investors Weigh In On Westlake Chemical Partners

Hedge funds have recently bought and sold shares of the business. Mariner LLC grew its stake in shares of Westlake Chemical Partners by 4.7% in the 4th quarter. Mariner LLC now owns 12,088 shares of the basic materials company’s stock worth $230,000 after buying an additional 538 shares in the last quarter. LPL Financial LLC increased its stake in Westlake Chemical Partners by 1.7% during the fourth quarter. LPL Financial LLC now owns 33,708 shares of the basic materials company’s stock worth $640,000 after acquiring an additional 579 shares during the last quarter. Royal Bank of Canada raised its position in Westlake Chemical Partners by 15.7% during the fourth quarter. Royal Bank of Canada now owns 7,749 shares of the basic materials company’s stock valued at $147,000 after purchasing an additional 1,050 shares during the period. Envestnet Asset Management Inc. lifted its stake in shares of Westlake Chemical Partners by 7.3% in the 3rd quarter. Envestnet Asset Management Inc. now owns 18,911 shares of the basic materials company’s stock valued at $397,000 after purchasing an additional 1,282 shares during the last quarter. Finally, Raymond James Financial Inc. boosted its holdings in shares of Westlake Chemical Partners by 7.2% in the 3rd quarter. Raymond James Financial Inc. now owns 22,654 shares of the basic materials company’s stock worth $476,000 after purchasing an additional 1,530 shares during the period. Hedge funds and other institutional investors own 78.28% of the company’s stock.

Westlake Chemical Partners Company Profile

(Get Free Report)

Westlake Chemical Partners LP (NYSE: WLKP) is a publicly traded master limited partnership sponsored by Westlake Chemical Corporation. The partnership owns, operates and acquires a portfolio of ethylene and vinyl manufacturing assets throughout the United States and the United Kingdom. As a downstream producer of basic chemicals and intermediates, WLKP supplies key industrial feedstocks to customers in a variety of end markets.

WLKP’s operations are organized into two primary segments: olefins and vinyls.

See Also

Earnings History for Westlake Chemical Partners (NYSE:WLKP)

Receive News & Ratings for Westlake Chemical Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Westlake Chemical Partners and related companies with MarketBeat.com's FREE daily email newsletter.